Cleared Traditional

K122404 - MODEL NUMBER: RMS1-2604, RMS1-2614, RMS1-2404, RMS1-2414, RMS2-2604, RMS2-2614, RMS2-2404, RMS2-2414, RMS3-2604, RMS3-26

K122404 is an FDA 510(k) clearance for MODEL NUMBER: RMS1-2604, manufactured by Repro-Med Systems, Inc. Dba Rms Medical Products. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 272-day FDA review.

K122404 · Repro-Med Systems, Inc. Dba Rms Medical Products · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
272d
Days
Class 2
Risk

K122404 is an FDA 510(k) clearance for the MODEL NUMBER: RMS1-2604, RMS1-2614, RMS1-2404, RMS1-2414, RMS2-2604, RMS2-261.... Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Repro-Med Systems, Inc. Dba Rms Medical Products (New York, US). The FDA issued a Cleared decision on May 6, 2013 after a review of 272 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K122404

510(k) Number K122404 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2012
Decision Date May 06, 2013
Days to Decision 272 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 129d · This submission: 272d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 932
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K122404.
MZ1000
K132413 · Care Fusion · Aug 2013
NEXUS IV TUBING SET WITH LUER-ACCESSBILE ONE-WAY CHECK VALVE - IV PLUS
K130879 · Nexus Medical, LLC · Jul 2013
NEXUS TKO-6P LUER ACTIVATED DEVICE
K130416 · Nexus Medical, LLC · Jun 2013
K100 NEUTRAL DISPLACEMENT NEEDLE FREE CONNECTOR
K130023 · Np Medical, Inc. · Apr 2013
ORBIT INFUSION SET
K130468 · Ypsomed AG · Mar 2013
MACLIN POWER INTRAVASCULAR ADMINISTRATION SET
K121511 · Maclin Power, Inc. · Mar 2013